LH - Laboratory Corporation of America Holdings

NYSE - NYSE Delayed Price. Currency in USD
159.06
+3.22 (+2.07%)
At close: 4:03PM EST
Stock chart is not supported by your current browser
Previous Close155.84
Open156.53
Bid0.00 x 0
Ask0.00 x 0
Day's Range156.23 - 159.76
52 Week Range126.44 - 164.22
Volume1,028,883
Avg. Volume671,117
Market Cap16.192B
Beta1.15
PE Ratio (TTM)22.18
EPS (TTM)7.17
Earnings DateFeb 14, 2018 - Feb 19, 2018
Forward Dividend & Yield0.00 (0.00%)
Ex-Dividend Date1994-03-29
1y Target Est173.53
Trade prices are not sourced from all markets
  • Capital Cube4 days ago

    ETFs with exposure to Laboratory Corp. of America Holdings : December 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Laboratory Corp. of America Holdings Here are 5 ETFs with the largest exposure to LH-US. Comparing the performance and risk of Laboratory Corp. of America Holdings with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)

  • American City Business Journals4 days ago

    LabCorp backs lawsuit challenging Medicare reimbursement rates

    In a lawsuit filed in federal court on Monday, the American Clinical Laboratory Association (ACLA) said the U.S. Centers for Medicare and Medicaid Services (CMS) “ignored Congressional intent” by putting in place the new system after the Protecting Access to Medicare Act was passed. “ACLA, LabCorp, and others in the laboratory industry have continued to address the serious deficiencies in the way that CMS has implemented PAMA,” said David King, chairman and chief executive officer of LabCorp in a statement.

  • Reuters5 days ago

    Medical lab trade group sues over U.S. reimbursement cuts

    A U.S. trade association representing medical laboratories filed a lawsuit on Monday challenging a new reimbursement system used by the federal government that it said would reduce how much Medicare pays for labs by about $670 million in 2018. The American Clinical Laboratory Association (ACLA) in a lawsuit in federal court in Washington, D.C., said the U.S. Centers for Medicare & Medicaid Services (CMS) ignored Congressional intent by implementing the new system following the passage of a 2014 law.

  • Business Wire5 days ago

    LabCorp Supports American Clinical Laboratory Association Lawsuit on PAMA Final Rule

    LabCorp , a leading global life sciences company, today issued the following statement regarding the lawsuit filed by the American Clinical Laboratory Association against the Acting Secretary of the U.S.

  • See what the IHS Markit Score report has to say about Laboratory Corporation of America Holdings.
    Markit12 days ago

    See what the IHS Markit Score report has to say about Laboratory Corporation of America Holdings.

    Laboratory Corporation of America Holdings NYSE:LH

  • LabCorp's Covance Business Bounces Back on Chiltern Buyout
    Zacks17 days ago

    LabCorp's Covance Business Bounces Back on Chiltern Buyout

    Despite a dull show for several quarters, LabCorp's (LH) Covance Drug Development reported strong growth in the third quarter, courtesy of Chiltern acquisition. However, volume woes remain.

  • Capital Cube19 days ago

    ETFs with exposure to Laboratory Corp. of America Holdings : November 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Laboratory Corp. of America Holdings Here are 5 ETFs with the largest exposure to LH-US. Comparing the performance and risk of Laboratory Corp. of America Holdings with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)

  • Laboratory Corp. of America Holdings breached its 50 day moving average in a Bullish Manner : LH-US : November 22, 2017
    Capital Cube24 days ago

    Laboratory Corp. of America Holdings breached its 50 day moving average in a Bullish Manner : LH-US : November 22, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Laboratory Corp. of America Holdings. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Reuters26 days ago

    Reimbursement cuts on lab tests pressure US lab firm shares

    A federal agency on Friday rolled out deep cuts to reimbursement rates for some lab tests under Medicare, a move that could save the government as much as $3 billion over five years, but hurt margins of U.S. laboratory companies. The cuts, which are expected to save about $670 million in Medicare payments in 2018, were roughly in line with a preliminary proposal published by the Centers for Medicare and Medicaid Services (CMS) in September. About three quarters of the more than 1,300 lab tests surveyed by the agency will be affected by the cuts, Canaccord Genuity analyst Mark Massaro said.

  • See what the IHS Markit Score report has to say about Laboratory Corporation of America Holdings.
    Markitlast month

    See what the IHS Markit Score report has to say about Laboratory Corporation of America Holdings.

    Laboratory Corporation of America Holdings NYSE:LH

  • LabCorp Reports New Use of Agilent's Cancer Diagnostic Test
    Zackslast month

    LabCorp Reports New Use of Agilent's Cancer Diagnostic Test

    The testing of the clinical studies needed to approve PD-L1 IHC 28-8 pharmDx assay's new indications were performed at LabCorp's (LH) Center for Molecular Biology and Pathology laboratory.

  • Barrons.comlast month

    [$$] Two Lawsuits Hit Express Scripts Unit on Pricing

    A securities filing made Tuesday by Express Scripts Holdings (ESRX) disclosed two large lawsuits that claim its subsidiary United Biosource helped drugmakers market their products in violation of antitrust and anti-kickback laws. The allegations in those suits touch on issues that Barron’s covered in a 2015 story that described how UBC’s contracts to promote drugmakers’ high-priced products seemed to conflict with the mission of its pharmacy benefit management parent: that is, to keep a lid on America’s drug bills (“Express Scripts Unit’s Connection to High Priced Specialty Drugs,” November 21, 2015). Other companies also named as defendants in the two suits were Eli Lilly & Co. (LLY) and Mallinckrodt PLC (MNK), as well as the Covance unit of Laboratory Corp. of America Holdings (LH).

  • Business Wirelast month

    LabCorp Announces New Expanded Use for PD-L1 Test with Bristol-Myers Squibb’s OPDIVO®

    LabCorp a leading global life sciences company, today announced the U.S. availability of the PD-L1 IHC 28-8 pharmDx assay as a complementary diagnostic for two newly approved indications in connection with the use of Bristol-Myers Squibb’s OPDIVO® to treat patients with metastatic urothelial carcinoma, also referred to as bladder cancer, and squamous cell carcinoma of the head and neck.

  • American City Business Journalslast month

    LabCorp firm partners with Canadian company to offer diagnostic tests for medical marijuana

    Dynacare, a Laboratory Corporation of America Holdings company, is partnering with MedReleaf Corp., a Canadian firm, to offer genetic diagnostic tests for medical cannabis.  The test, called ReleafDxTM, ...

  • ACCESSWIRElast month

    Earnings Review and Free Research Report: Labcorp’s Revenue Jumped 9.5%; Raised Outlook for 2017

    Research Desk Line-up: Charles River Laboratories Post Earnings Coverage LONDON, UK / ACCESSWIRE / November 14, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Laboratory Corp. ...

  • Business Wirelast month

    LabCorp Receives 2017 Partnership Award from Be The Match®

    LabCorp, , a leading global life sciences company that is deeply integrated in guiding patient care, proudly announces that it received the 2017 Partnership Award from Be The Match® on November 11 at the nonprofit’s 30th Annual Council Meeting in Minneapolis.

  • Business Wirelast month

    LabCorp Earns 100 Percent on Human Rights Campaign Foundation’s 16th Annual Scorecard on LGBTQ Workplace Equality

    LabCorp , a leading global life sciences company, announced that it received a perfect score of 100 percent on the 2018 Corporate Equality Index , a national benchmarking survey and report on corporate policies and practices related to lesbian, gay, bisexual, transgender and queer workplace equality, administered by the Human Rights Campaign Foundation.

  • GlobeNewswirelast month

    OmniSeq Receives CAP Accreditation and Publishes Analytical Validation Paper

    BUFFALO, N.Y., Nov. 09, 2017-- OmniSeq, Inc., a molecular diagnostics subsidiary of Roswell Park Cancer Institute, announced today that it received accreditation by the College of American Pathologists, ...

  • Capital Cubelast month

    ETFs with exposure to Laboratory Corp. of America Holdings : November 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Laboratory Corp. of America Holdings Here are 5 ETFs with the largest exposure to LH-US. Comparing the performance and risk of Laboratory Corp. of America Holdings with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)

  • Laboratory Corp. of America Holdings :LH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017
    Capital Cubelast month

    Laboratory Corp. of America Holdings :LH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017

    Categories: Yahoo FinanceGet free summary analysis Laboratory Corp. of America Holdings reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Laboratory Corp. of America Holdings – Quest Diagnostics Incorporated, NeoGenomics, Inc. and IDEXX Laboratories, Inc. (DGX-US, NEO-US and IDXX-US) that have also reported for this period. ... Read more (Read more...)

  • Laboratory Corp. of America Holdings breached its 50 day moving average in a Bullish Manner : LH-US : November 6, 2017
    Capital Cubelast month

    Laboratory Corp. of America Holdings breached its 50 day moving average in a Bullish Manner : LH-US : November 6, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Laboratory Corp. of America Holdings. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Business Wirelast month

    LabCorp is Scheduled to Present at the 26th Annual Credit Suisse Healthcare Conference

    LabCorp® today announced it will participate at the 26th Annual Credit Suisse Healthcare Conference. LabCorp’s presentation is planned for Tuesday, November 7, 2017 at 10:55 am .

  • American City Business Journalslast month

    LabCorp partners with Northeast provider on lab testing

    Laboratory Corporation of America Holdings (LH) is partnering with Capital Health, a provider in Central New Jersey and Lower Bucks County, Pa., to provide laboratory tests. Capital Health’s hospital laboratories will also perform emergency tests, which will be supported by LabCorp.

  • LabCorp and Capital Health Enter Comprehensive Laboratory Partnership
    Business Wirelast month

    LabCorp and Capital Health Enter Comprehensive Laboratory Partnership

    LabCorp® , a leading global life sciences company, and Capital Health, the Central New Jersey/Lower Bucks County, Pennsylvania region’s leader in providing progressive, quality patient care, announced today that they have entered into a comprehensive laboratory partnership.

  • CVS buys Aetna for $69B
    Yahoo Finance Video12 days ago

    CVS buys Aetna for $69B

    It's a deal that may shake up the entire health care industry. CVS is buying Aetna for $69B in cash and stock. Yahoo Finance’s Alexis Christoforous and Rick Newman figure out what this means for the health care industry.